Centre Hospitalier De Saint-Quentin

At Centre Hospitalier De Saint-Quentin, clinical research in the neoplasms area focuses on advanced prostate cancer, especially metastatic castration-resistant prostate cancer. These studies are designed to assess whether new treatment combinations can improve survival and delay disease progression.

• Evaluating a new therapy approach for advanced prostate cancer
• Measuring impact on overall survival and disease control
• Exploring better treatment effectiveness for patients with resistant disease

This work reflects a strong interest in improving outcomes for hard-to-treat cancer, with a clear focus on treatment benefit and long-term disease management.

The site also studies bacterial infections affecting the lungs, with attention to Mycobacterium xenopi pulmonary infection. This research aims to determine whether adding a targeted inhaled treatment can improve infection clearance compared with standard care alone.

• Studying a lung infection caused by Mycobacterium xenopi
• Assessing improvement in sputum conversion and infection control
• Testing whether an added therapy can strengthen standard treatment

Through this infectious disease program, Saint Quentin contributes to efforts that may improve diagnosis-related outcomes and treatment success for difficult pulmonary infections.